Heron Therapeutics Q3'26 Earnings Preview
Heron Therapeutics is expected to report Q3'26 results on November 9 before the market opens. Revenue and EPS estimates were provided.
Related stories
HENT Signs NOK 208 Million Contract With SVG Property
HENT signed a NOK 208 million contract with SVG Property for an office building in Stavanger.
M impact | EQUITY | Nov 02, 2026, 03:30 PM UTC
Cipher Digital reports quarterly results for quarter ended September 30
Cipher Digital reported results for the quarter ended September 30. The supplied body contains no result figures.
M impact | EQUITY | Nov 02, 2026, 03:30 PM UTC
Sentia Subsidiary HENT Wins NOK 208 Million Office Contract
HENT signed a NOK 208 million contract, excluding VAT, with SVG Property to build an approximately 5,000-square-meter office building in Stavanger. Construction is scheduled to sta
M impact | EQUITY | Nov 02, 2026, 03:30 PM UTC
Usio Schedules Q3 Fiscal 2026 Results Call and Company Update
Usio says it will hold a third-quarter fiscal 2026 results conference call and company update on November 10, 2026.
M impact | EQUITY | Nov 02, 2026, 03:30 PM UTC
Publix Reports Third-Quarter 2026 Results
Publix reported sales of $15 for the three months ended Sept. 26, 2026.
M impact | EQUITY | Nov 02, 2026, 03:30 PM UTC
Oracle raises funds from investors to expand AI business
Oracle raised funds from investors to fund expansion of its AI business, according to a regulatory filing submitted Monday, Reuters reports.
L impact | EQUITY | Nov 02, 2026, 03:30 PM UTC